Trana Develops Assay That ID’s Protein That Helps HIV Replicate | GenomeWeb
Trana Discovery announced this week that its HIV high-throughput screening assay, designed to identify compounds that inhibit the use of tRNA, which is required for HIV replication, can select compounds with anti-HIV bioactivity.
 
According to the company, disrupting the virus’s ability to use tRNA may represent a novel target for antiretroviral therapy. Trana plans to license the assay to pharma companies that will use it to screen “several hundred thousand, maybe even millions, of compounds.”
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.